Results 151 to 160 of about 111,791 (264)

The BREV neuropsychological test: Part II. Results of validation in children with epilepsy [PDF]

, 2002
C. Billard, J. Motte, Mary E. Farmer, M.O. Livet, Louis Vallée, Pierre Gillet, S. Vol   +6 more
openalex   +1 more source

Exploring the role of apolipoprotein ε4 in progressive myoclonic epilepsy type 1

Epileptic Disorders, EarlyView.
Abstract Objective Progressive myoclonic epilepsy type 1 (EPM1) is a neurodegenerative disease caused by biallelic variants in the cystatin B (CSTB) gene. Despite a progressive course, phenotype severity varies among patients, even within families. We studied the potential role of APOE ε4 in modifying phenotypic diversity in EPM1, given its established
Janina Gunnar, Yawu Liu, Henri Eronen, Tarja Joensuu, Marja Äikiä, Jelena Hyppönen, Katri Silvennoinen, Esa Mervaala, Juhana Hakumäki, Anna‐Elina Lehesjoki, Reetta Kälviäinen   +10 more
wiley   +1 more source

The Use of Mismatch Negativity in Conjunction with Neuropsychological Tests to Discriminate Alzheimer's Dementia, Mild Cognitive Impairment and Healthy Aging. [PDF]

Noro Psikiyatr Ars
Özbayrak-Karapınar D, Arısoy Ö, Yıldız N.   +2 more
europepmc   +1 more source

The Retrograde Memory for News Events Test (RM-NET) and the relationship between news event memory and performance on standard neuropsychological tests. [PDF]

Learn Mem, 2022
Cawley-Bennett ATJ, Frascino JC, Asp IE, Golshan S, Bondi MW, Luo Z, Smith CN.   +6 more
europepmc   +1 more source

Neuropsychological Tests of Memory, Visuospatial, and Language Function in Parkinson's Disease: Review, Critique, and Recommendations. [PDF]

Mov Disord
Bezdicek O, Biundo R, Boelema S, Cammisuli DM, Cholerton B, Cronin-Golomb A, Dalrymple-Alford JC, Duits A, Fellows R, Gerstenecker A, El Hachioui H, Horáková H, Koerts J, Levin B, Liepelt-Scarfone I, Sarno M, Mestre TA, Ferro ÁS, de Siqueira Tosin MH, Skorvanek M, Weintraub D, Geurtsen GJ, members of the IPMDS Clinical Outcome Assessment Scientific Evaluation Committee.   +22 more
europepmc   +1 more source

Evaluation of cognitive dysfunction by the clock drawing test in multiple sclerosis and clinically isolated syndrome patients: Correlation with other neuropsychological tests. [PDF]

Neurosciences (Riyadh), 2022
Tekin S, Bir LS, Oncel C, Unluturk Z, Aydın E.   +4 more
europepmc   +1 more source

A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson’s disease [PDF]

, 2018
Naomi Kokubo, Yuma Yokoi, Yuji Saitoh, Miho Murata, Kazushi Maruo, Yoshitake Takebayashi, Issei Shinmei, Sadanobu Yoshimoto, Masaru Horikoshi   +8 more
openalex   +1 more source

Efficacy of vagus nerve stimulator during transition to adulthood in patients with treatment‐resistant epilepsy

Epileptic Disorders, EarlyView.
Abstract Objective To evaluate the efficacy of vagus nerve stimulation (VNS) as an adjunctive treatment in pediatric patients with treatment‐resistant epilepsy during the transition to adolescence. Methods We performed a retrospective cohort study of 30 children (ages 2–18 years) with medication‐resistant epilepsy who underwent VNS implantation between
Jonadab dos Santos Silva, Shaylla Villas Boas, Henrique Januzzelli Pires do Prado, Daniela Fontes Bezerra, Isabella D’Andrea Meira   +4 more
wiley   +1 more source

Moving toward the digitalization of neuropsychological tests: An exploratory study on usability and operator perception. [PDF]

Digit Health
Maggio MG, Giambò FM, Barbera M, De Pasquale P, Bruno F, Calderone A, Quartarone A, Rizzo A, Calabrò RS.   +8 more
europepmc   +1 more source

Neuropsychological Tests in Post-operative Cognitive Dysfunction: Methods and Applications. [PDF]

Front Psychol, 2021
Liu J, Huang K, Zhu B, Zhou B, Ahmad Harb AK, Liu L, Wu X.   +6 more
europepmc   +1 more source